Smithfield Trust Co
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1019754
PITTSBURGH, PA
Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$256,516
-$17,497 QoQ
Shares Held
332
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Smithfield Trust Co holds $563,573 across 10 Biotechnology names. REGN ranks #1 (45.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
332 | $256,516 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503 | $224,609 | |
| 3 | INCY |
Incyte Corp
|
323 | $30,400 | |
| 4 | RPRX |
Royalty Pharma plc
|
603 | $28,925 | |
| 5 | CYTK |
Cytokinetics Inc
|
155 | $10,216 | |
| 6 | TECH |
BIO-TECHNE Corp
|
148 | $7,734 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
606 | $2,393 | |
| 8 | ARGX |
Argenx SE
|
2 | $1,460 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $256,516 | 332 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $274,013 | 355 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $193,983 | 345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $64,575 | 123 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $86,889 | 137 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $97,589 | 137 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $144,019 | 137 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $148,195 | 141 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $143,411 | 149 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $123,838 | 141 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $116,037 | 141 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $91,254 | 127 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $104,352 | 127 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $91,629 | 127 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $87,486 | 127 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $75,073 | 127 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $88,699 | 127 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $65,678 | 104 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $62,938 | 104 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $58,087 | 104 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $49,206 | 104 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $50,242 | 104 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $148,341 | 265 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $165,890 | 266 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||